58.44
-0.52(-0.88%)
Currency In USD
| Previous Close | 58.96 |
| Open | 57.84 |
| Day High | 59.89 |
| Day Low | 57.51 |
| 52-Week High | 63.86 |
| 52-Week Low | 29.31 |
| Volume | 1M |
| Average Volume | 2.17M |
| Market Cap | 6.99B |
| PE | -11.41 |
| EPS | -5.12 |
| Moving Average 50 Days | 48.47 |
| Moving Average 200 Days | 41.85 |
| Change | -0.52 |
If you invested $1000 in Cytokinetics, Incorporated (CYTK) 10 years ago, it would be worth $8,420.75 as of October 19, 2025 at a share price of $58.44. Whereas If you bought $1000 worth of Cytokinetics, Incorporated (CYTK) shares 5 years ago, it would be worth $3,528.99 as of October 19, 2025 at a share price of $58.44.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Cytokinetics Presents New Data Related to Aficamten at the HFSA Annual Scientific Meeting 2025
GlobeNewswire Inc.
Sep 29, 2025 11:30 AM GMT
Additional Data from MAPLE-HCM Show Aficamten Significantly Improves Measures of Maximaland Submaximal Exercise Capacity and Recovery Compared to Metoprolol 96-Week Analyses from FOREST-HCM SupportLong-Term Efficacy and Tolerability of Aficamten in P
Cytokinetics Announces Call for Proposals for Its Eighth Annual Communications Grant Program
GlobeNewswire Inc.
Sep 24, 2025 11:30 AM GMT
Program to Provide Support of Communications and Outreach for Patient Advocacy Organizations Focused on Cardiovascular Diseases Deadline for Applications is November 3rd, 2025 SOUTH SAN FRANCISCO, Calif., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Cytokine
Cytokinetics to Present at the Stifel 2025 Virtual Cardiometabolic Forum
GlobeNewswire Inc.
Sep 23, 2025 8:00 PM GMT
SOUTH SAN FRANCISCO, Calif., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that members of the Company’s management team are scheduled to present a corporate update at the Stifel 2025 Virtual Cardiomet